For more than a year, the Corona virus and its effects have been daily companions of the world population. Various vaccine serums against the virus are now being successfully used, but until now there has been no medication to stop the disease. In the EU project EXSCALATE4CORONAVIRUS, researchers from Forschungszentrum Jülich now presented a prediction of which molecules could inhibit the main protease of SARS CoV 2.
The world's largest plant for storing green hydrogen in liquid organic hydrogen carriers (LOHC) on an industrial scale is being built at CHEMPARK Dormagen. North Rhine-Westphalia is supporting the project with a total of 9 million euros. LOHC Industrial Solutions NRW GmbH, a subsidiary of the Erlangen-based company Hydrogenious LOHC Technologies, is responsible for project management and plant operation. Another industrial partner is Covestro Deutschland AG.
The JARA partner RWTH Aachen University has again been certified as performing positively in the QS Ranking by Subject for the year 2021. RWTH performed particularly well in the Engineering and Technology category, achieving the world ranking of 43 – placing it second among German universities. The university also performed well in individual disciplines.
Groundbreaking science needs the right environment and the right expertise. A good example of this is the JARA Institute for Quantum Information (JARA-IQI), whose home is RWTH Aachen University and Forschungszentrum Jülich. In this highly reputed technological environment, the scientists of the JARA-IQI Institute are researching and working on the realization of a quantum computer to meet the challenges of modern society. The new video illustrates which paths and approaches the researchers of the JARA-IQI Institute are pursuing.
For many years, rare diseases have been a research focus of JARA-BRAIN member Prof. Jörg B. Schulz. Now the physician is also involved in the project "Collaboration on Rare Diseases (CORD)", which is funded by the German Federal Ministry of Education and Research with several million euros as part of the Medical Informatics Initiative. The new project offers the opportunity to collaborate across disciplines with numerous partners in this field to improve the quality of life of patients with rare diseases.